Trypanosoma brucei Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public-Private Partnership to Identify Novel Leads

BACKGROUND: Trypanosoma brucei, the causative agent of Human African Trypanosomiasis (HAT), expresses two proteins with homology to human glycogen synthase kinase 3β (HsGSK-3) designated TbruGSK-3 short and TbruGSK-3 long. TbruGSK-3 short has previously been validated as a potential drug target and...

Descripción completa

Detalles Bibliográficos
Autores principales: Oduor, Richard O., Ojo, Kayode K., Williams, Gareth P., Bertelli, Francois, Mills, James, Maes, Louis, Pryde, David C., Parkinson, Tanya, Van Voorhis, Wesley C., Holler, Tod P.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071371/
https://www.ncbi.nlm.nih.gov/pubmed/21483717
http://dx.doi.org/10.1371/journal.pntd.0001017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071371/
https://www.ncbi.nlm.nih.gov/pubmed/21483717
http://dx.doi.org/10.1371/journal.pntd.0001017

Ejemplares similares